Neonatal respiratory failure due to novel compound heterozygous mutations in the ABCA3 lipid transporter

Zoltán N. Oltvai, Eric A. Smith, Katie Wiens, Lawrence M. Nogee, Mark Luquette, Andrew C. Nelson, Kathryn A. Wikenheiser-Brokamp

Research output: Contribution to journalArticle

Abstract

The ATP-binding cassette transporter member A3 (ABCA3) is a lipid transporter with a critical function in pulmonary surfactant biogenesis. Biallelic loss-of-function mutations in ABCA3 result in severe surfactant deficiency leading to neonatal respiratory failure with death in the first year of life. Herein, we describe a newborn with severe respiratory distress at birth progressing to respiratory failure requiring transplant. This patient was found to have a maternally inherited frameshift loss-of-function ABCA3 mutation and a paternally inherited synonymous variant in ABCA3 predicted to create a cryptic splice site. Additional studies showed reduced ABCA3 expression in hyperplastic alveolar epithelial type II cells and lamellar body alterations characteristic of ABCA3 deficiency, leading to a diagnosis of autosomal recessive ABCA3-related pulmonary surfactant dysfunction. This case highlights the need for an integrated, comprehensive approach for the diagnosis of inherited diseases when in silico modeling is utilized in the interpretation of key novel genetic mutations.

Original languageEnglish (US)
JournalCold Spring Harbor Molecular Case Studies
Volume6
Issue number3
DOIs
StatePublished - Jun 1 2020

Keywords

  • cyanosis
  • progressive pulmonary function impairment
  • respiratory insufficiency

PubMed: MeSH publication types

  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint Dive into the research topics of 'Neonatal respiratory failure due to novel compound heterozygous mutations in the ABCA3 lipid transporter'. Together they form a unique fingerprint.

  • Cite this